In the News

Recent Coverage of HMS in the News
May 10, 2015

Alvaro Pascual-Leone, professor of neurology at Beth Israel Deaconess Medical Center, and Lee M. Nadler, dean for clinical and translational research at HMS, the Virginia and D.K. Ludwig Professor of Medicine at Dana-Farber Cancer Institute and director of Harvard Catalyst, authored this piece about the Football Players Health Study at Harvard University.

May 10, 2015

The Boston Marathon bombings tied the wounded to one another, to the caregivers who saved their lives and to strangers who were nearby, forming relationships that have given them solace in their transformed lives. George Dyer, assistant professor of orthopedic surgery at Brigham and Women’s Hospital, is quoted.Spaulding Rehabilitation Hospital is mentioned.

May 10, 2015

Allen Kachalia, associate professor of medicine at Brigham and Women's Hospital, coauthored this opinion piece about overuse and waste in medical care. 

May 7, 2015

Johnson & Johnson has appointed a nationally known bioethicist to create a panel that will make decisions about patients’ requests for potentially lifesaving medicine, responding to an emotional debate over whether companies should allow desperately ill people to have access to the drugs before they are approved. Aaron Kesselheim, associate professor of medicine at Brigham and Women’s Hospital, is quoted.

May 6, 2015

Lesbian, gay and bisexual adolescents are more likely to be bullied and victimized throughout elementary and high school than heterosexual students, according to new research. Mark Schuster, William Berenberg Professor of Pediatrics at Boston Children's Hospital, is the lead author of the study.

May 5, 2015

The accidental death of Dave Goldberg, CEO of SurveyMonkey, led to predictable follow-up stories on the dangers of exercising on treadmills. Eddie Phillips, assistant professor of physical medicine and rehabilitation at Spaulding Rehabilitation Hospital, and Aaron Baggish, assistant professor of medicine at Massachusetts General Hospital, are quoted.

May 5, 2015

When the FDA approved a drug called Colcrys to treat acute gout attacks, the move came as part of an agency initiative to regulate medicines that had never been formally approved, but were on the market when the FDA received authority to oversee the drug approval process. In this instance, Colcrys was the brand name given colchicine, which was sold for decades by several companies and cost 9 cents a pill. URL Pharma won FDA approval – and seven years of marketing exclusivity – by running a small study that gauged the effectiveness of different dosages. URL sued other colchicine makers and, by early 2011, marketing exclusivity took hold. And Colcrys cost $5 a pill. Now, a new study says the approval was not worth the effort, at least for patients. Aaron Kesselheim, associate professor of medicine at Brigham and Women's Hospital, is a study coauthor.

May 4, 2015

A personalized method for interpreting blood tests identifies more ovarian cancer cases than a generalized approach, a new study suggests. Steven Skates, associate professor of medicine at Massachusetts General Hospital, is a coauthor of the research.

Pages

Resources

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community,  click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.